Ethyl 2-(5,6-dimethyl-4-oxofuro[2,3-d]pyrimidin-3(4H)-yl)acetate, 95%, 250mg

4-Bromo-2,6-difluorophenyl isothiocyanate, 95.0%, 1g

Technical ethanol, denatured, min. 98%, 2.5 l, glass packaging

(5E)-2-mercapto-5-(3-methoxybenzylidene)-1,3-thiazol-4(5H)-one, 95.0%, 5g

(E)-Ethyl 3-(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylate, 98%, 100mg

1-Bromo-2,6-dichlorobenzene, 99.0%, 250g

Methyl 3-(2-hydroxyethyl)benzoate, 98%, 100mg

2-Amino-5-tert-butyl-benzonitrile, 95.0%, 1g

4-Chloro-3,5-difluoro-pyridine-2-carbaldehyde, 98+%, 250mg

anti-Glial Fibrillary Acidic Protein mouse monoclonal, GF 12.24, 1 ml

Benzyl (2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate, 95%, 1g

1,5-Anhydro-3,4,6-tri-O-benzyl-2-deoxy-D-arabinohex-1-enitol, 99.0%, 10g

(R)-4-ISOPROPYL-2-(QUINOLIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 100mg